Preparing the combined turkey-duck-chicken dish requires patience and persistence, which are good qualities for a value investor to possess.
Good traders can make money even with poor stocks if they use an effective trade management system.
Reata Pharmaceuticals and Axsome Therapeutics each have had a terrific 2019, which helps offset the losing bets in this high-beta sector of the market.
Investors need to do what works for them in markets where trading action is extremely random.
It is to work at it every day, day after day, year after year.
The worse the market action becomes, the greater the likelihood it eventually will produce a new crop of sweet opportunities; here's how to find them.
Research from Value Line, S&P, Morningstar and the like are useful when looking at stocks, but before acting on the suggestions, remember to take a whiff and see if they're no good.
A look at the action on several stocks -- Chipotle, Shopify, Nucor and even Ulta Beauty -- shows this market is kind and offering up some juicy discounts.
Let's examine the hard-hit cloud stocks from a technical point of view.
We run Medical Properties Trust through our dividend-metric gauntlet to see whether the healthcare REIT can maintain its payout pace.